Mike Pence on Leadership and the Future of the Republican Party
Former US Vice President Mike Pence looks back on the events of January 6 2021, his final days in office with President Trump and his…
Thought Leader: Mike Pence
Good-bye to My Pal, FDA Commissioner Scott Gottlieb
By Scott Gottlieb (Original source The Cut)
Well, shoot.
“The FDA commissioner Scott Gottlieb announced his unexpected resignation on Tuesday, in a letter the FDA tweeted. The reasons are unclear, but it leaves a lot of people extremely disappointed, myself among them. (He’s been commuting to D.C. from Connecticut and says he misses his wife and young family.)
Since his appointment in May of 2017, Gottlieb has earned wide bipartisan support as a public-health advocate (also unexpected, given his previous ties to the pharmaceutical industry), due in large part to his efforts to curb the opioid epidemic, which he told CNN last year was the “biggest crisis” facing the FDA. “Gottlieb has been shockingly good so far,” Stanford public policy expert Keith Humphreys told Vox. (However, Harvard professor and FDA-scrutinizer Daniel Carpenter said the “jury is still out” on Gottlieb’s legacy, in an interview with STAT.)”
Click here to see more
Relevant and recent posts
Marc Short on U.S. Investment in Critical Minerals
Why do critical minerals matter now? Marc Short explains how U.S. investment in critical minerals fits into a broader strategy around economic security, manufacturing, and…
Thought Leader: Marc Short
Marc Short on AI Policy and the Government’s Role in Chip Technology Investment
On CNBC, Marc Short breaks down the role of AI policy and how government investment is shaping the future of chip technology. A former Chief…
Thought Leader: Marc Short
More with this speaker
Dr. Scott Gottlieb on Finding Cures for Rare Diseases
Thought Leader: Scott Gottlieb
Dr. Scott Gottlieb: What’s Next for Childhood Vaccines
Thought Leader: Scott Gottlieb
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb